Canopy Growth has announced that that shareholders of MTL Cannabis have voted to approve the Company's previously announced acquisition of MTL at a special meeting of shareholders of MTL held February 17, 2026.
The plan of arrangement with Canopy Growth received overwhelming support from MTL Shareholders, with (i) 99.97% of all shares of MTL cast in favour of the special resolution approving the transaction, and (ii) 99.80% of MTL Shares, excluding votes attached to MTL Shares required to be excluded pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions, cast in favour of the special resolution approving the Transaction.
Approximately 89% of MTL Shareholders participated in the vote, demonstrating broad support for the combination. Further details on the vote are provided for in MTL's press release dated February 18, 2026.
"The strong shareholder support received today marks a significant milestone toward completing this strategically compelling combination of two organizations that will create Canada's leading medical cannabis company," said Luc Mongeau, Chief Executive Officer, Canopy Growth. "By combining MTL's cultivation capabilities with our scale, we're creating a more robust and competitive platform for long-term success in the Canadian and regulated international markets. We're grateful to MTL shareholders for endorsing this vision and look forward to the opportunities ahead."
For more information:
Canopy Growth Corp.
[email protected]
canopygrowth.com
